TE_10363
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 362.92 |
| Counts of samples | TCGA_tumor:321; TCGA_normal:0; GTEx:0 |
| TSS | chr4(+):4959532 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_10363.1 | - | Intergenic | Non-coding | Non-coding | chr4(+):4959533,4959575,4959807,4959947,5004545,5004708,5005708,5005728 |
| teRNA_10363.2 | - | Intergenic | Non-coding | Non-coding | chr4(+):4959533,4959575,4959807,4959947,5004545,5004708,5011647,5011667 |
| teRNA_10363.3 | - | Intergenic | Non-coding | Non-coding | chr4(+):4959533,4959575,4959807,4959947,4977812,4977832 |
| teRNA_10363.4 | - | Intergenic | Non-coding | Non-coding | chr4(+):4959533,4959575,4959807,4959947,5001612,5001632 |
| teRNA_10363.5 | - | Intergenic | Non-coding | Non-coding | chr4(+):4959533,4959575,4959807,4959947,5004545,5004633,5011647,5011667 |
| teRNA_10363.6 | - | Intergenic | Non-coding | Non-coding | chr4(+):4959533,4959575,4959807,4959947,4988482,4988502 |
| teRNA_10363.7 | - | Intergenic | Non-coding | Non-coding | chr4(+):4959533,4959575,4959807,4959947,4976631,4976651 |
| teRNA_10363.8 | - | Intergenic | Non-coding | Non-coding | chr4(+):4959533,4959575,4959807,4959947,4960676,4960696 |
| teRNA_10363.9 | - | Intergenic | Non-coding | Non-coding | chr4(+):4959533,4959575,4959807,4959947,4976631,4976712,4977812,4977832 |
| teRNA_10363.10 | - | Intergenic | Non-coding | Non-coding | chr4(+):4959533,4959575,4959807,4959947,5004545,5004708,5005627,5005647 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
